Generalized lymphangiectasia is a rare congenital disorder characterized by dilated lymphatic vessels with a fatal prognosis, especially in cases with thoracic involvement. We describe the use of propranolol in the therapy of generalized lymphangiectasia in a preterm infant with hydrops fetalis. Propranolol was well tolerated and effective within the first months. It remains to be shown whether propranolol is a treatment option for infants with generalized lymphangiectasia.
Treatment of Congenital Generalized Lymphangiectasia With Propranolol in a Preterm Infant
FINANCIAL DISCLOSURE: The authors have indicated they have no financial relationships relevant to this article to disclose.
- Views Icon Views
- Share Icon Share
- Search Site
Christine Poralla, Sabine Specht, Mark Born, Annette Müller, Peter Bartmann, Andreas Müller; Treatment of Congenital Generalized Lymphangiectasia With Propranolol in a Preterm Infant. Pediatrics February 2014; 133 (2): e439–e442. 10.1542/peds.2012-2087
Download citation file: